Ikarian Capital »

BioCryst Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $168k 17k 10.00
2021-09-30 $3.6M 250k 14.37

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
TCG Crossover Management
Perceptive Advisors
Jupiter Topco
Henderson Group
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Standard Life Aberdeen
UBS Group

View all funds holding BioCryst Pharmaceuticals